About Us
A CONSERVATOR OF HEALTH & WELLNESS
CULMINATE H [CH] is a biotech focused on the formulating and manufacturing of vitamins, minerals, and supplements (VMS). CH also specializes in developing functional foods and beverages. CH’s acumen and IP strategy possess an exclusive recipe on how to deliver essential and life extending ingredients that promote the manufacturing of proteins in the human body.
What
a wellness conservator engaged in the formulation, development, manufacturing, and distribution of dietary nutritional supplements.
How
big data aggregation coupled with genome sequencing, the science of cellular nutrition, and effective delivery systems that yield prescriptive wellness solutions.
Why
now more than ever adults seek peak health, wellness and a balanced lifestyle in order to ensure longevity, optimal health and quality of life.
Our Revolution
ELEVATING THE HUMAN CONDITION
A Profound Possibility
1979-1990;
The successful extraction and use of ultra filtrate peptides comprised of tissues and endocrine glads derived from embryonic ovine placenta stem cells.
Give Life to Humans
1980-1995;
Effective hydrolysis reaction through macromolecules ruptures that increase increasing and actuate the appropriate enzymes, suitable pH and temperature variations to yield a mixture of potent and sophisticated amino acids
The Recipe to Cell Life
1980-1997;
Optimal fragmentation through hydrolysis yielding a polypeptides, dipeptides and amnio acids in addition to their natural tissues which contain complex proteins (phosphor-proteins, nucleiproteins, glycoproteins, lipoproteins and metabolicproteins)
Cellular Optimization
1981-2001;
Optimal yield of supplemental building block components: phosphorus compounds, nucleic acids and nucleotides. All derived from carbohydrates and lipids, biological cofactors, trace elements and electrolytes, in addition to lysis protein derivatives.
Orthomolecular Revival
1983-2001;
Comprehensive implementation of lysed-process resulting in optimal normalization of structure, physiology and the metabolism of a particular tissue or organ.
Cellular Optimization
1979-2005;
Optimal cell and regeneration cocktail comprised of tissue / organ specific protein, amino acids, hydrolysates, vitamins, trace elements, minerals and herbal elements to complement and potentiate the function of the hydrolysates with the placenta stem cells.
Giver of Life 64
1979-2005;
Successful implementation and administration of proteolytic enzymes to reduce a range of complex proteins, polypeptides and oligopeptides peptones in order to achieve maximum reach of amino acids.
Our Team
AN ALL STAR TEAM & BOARD WITH 100+ YEAR OF COMBINED EXPERIENCE & SUCCESS.
Dr. Calixto Vallejo
Co-Founder, Chief Director of Operations responsible for all operational frameworks between production, sales and partner networks. 30 years experience in manufacturing, input/ output analysis, and operational optimization for fortune 500 industry leaders.
Rudy Prajza
Strategic Marketing & Advertising Advisor, NonExecutive Board Member, advises on all strategic marketing and advertisement initiatives. This includes consumer analysis and predictive modeling. 40+ years experience in executive marketing and advertisement roles for fortune 500 FMCG conglomerates like Coke and Pepsi.
Armando Mendez
Commercial Financing & Big Box Retailer Strategic Advisor; Non-Executive Board Member, advises on all commercial financing strategies, inventory collaborations, and liquidity as it pertains to big box retailers like Walmart and Target. 40+ experience in the executive management within the sport apparel industry holding exclusive licensing with MLB and 30+ years as vendor with Walmart.
Dr. Oscar Kuperman
Strategic Corporate Structure & Finance Advisor, Non-Executive Board Member, advises on all strategic corporate finance strategies and structures. 35+ years experience as accomplished investment banker and corporate finance executive in equity structuring with JB Morgan Chase, Morgan Stanley, Goldman Sachs and Citigroup managing multi-billion dollar funds with a large team of associates.
Cathy Cash Spellman
Strategic Branding & Marketing Advisor, NonExecutive Board Member, advises strategic branding and marketing beauty initiatives, a best seller author with 40+ years experience in VP executive and consulting roles in branding and marketing for fortune 500 beauty and wellness conglomerates.
Steven Sullivan
Strategic New Product Development & Commercial Advisor, Non-Executive Board Member, advises all strategic new product development and commercialization initiatives with 40+ years experience in ownership and VP of sales within the food and beverage industry working with the largest wine and spirits conglomerates in the world.
Dr. Juan Carlos Rodriguez
Co-Founder, Scientist, Chief Commercial Officer, responsible for all commercial and operational functions with emphasis in IP strategy, protection, and monetization via licensing and partner compliance. 25 years experience in manufacturing, commercialization strategies, input/output analysis, IP strategy/monetization, operational optimization, and financial modeling with fortune 500 companies occupying the energy, life science, biotech, FMCG space.
Gustavo Bravo
Chief Corporate Console, oversees the compliance of all contractual documentation, reinforcing our IP strategy/protection (trademarks & patents) while assisting in minimizing exposure & liabilities. Ultimately ensuring CH LABS is preemptive to deescalate any litigious uprising from any/all business relationships and or competitors.
Aramando Allen
Chief Sport Advisor & Coach, oversees our sports wellness and education programs for our highschool, university, and professional athletic initiatives and endorsements regarding safety, health, and nutrition. As an ex professional football player and university coach Armando brings 15 years experience in team collaboration, good worth ethics, and mentorship.
Lisa Capote
FDA Liaison & Console, oversees all FDA compliance, claims, and labeling while assisting in minimizing exposure & liabilities to product formulas and brands. Ultimately ensuring CH LABS is preemptive to deescalate any litigious uprising from any/all FDA requirements or business matters.
References
RESEARCH PUBLICATIONS & CASE STUDY REFERENCES
Center for Cellular Therapy & Cytoplasmic Information and Library Archive; Volume 1, 1076-1982, Cytoplasmic Biology, ovine placenta stem cells.
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; 2n.d Simposium Cellular Therapy, (1988)
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 1, (1993)
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 2, clinical trials, (1993)
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Nestor E. Bravo, Irene A. Funai; Advances en plastic surgery and repair in the pre and post surgical procedures with molecular nutrition, (1994).
Dr. Santiago Caleque; brief clinical overview in the following cellular and molecular therapies via the use of thymus glands and placenta cotyledon tissues for the mediation of biological conditions, (1996).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; a 13 part system outlining molecular therapies specific to organ tissues and their optimal function, (1997).
Dr. Santiago Caleque, Dr. Aaron Erenfryd; cellular and organ therapies via macromolecular nutrition, (1997).
Dr. Santiago Caleque; pluripotent cells revitalization via macromolecular tissue therapies, (1998).
Dr. Santiago Caleque; therapy protocols in molecular tissues, (1999).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; blastema tissues, the fundamentals of mesenchymal stem cells (2000).
Dr. Santiago Caleque, Dr. Ruben O. Muhlberger, Dr. Eduardo Arganaras; prophylaxis for aging and metabolic conditions via molecular tissue therapies, (2000)
Dr. Hayde Losa; delivery absorption of hydrolyzed molecular tissue cocktails, (2009)
Dr. Eradio Ignacio Minotti; Advances In Cellular Biology, the human genome, cell Life, & modern integrated Health, (2015).
Our Differentiators
Driven by science our research platform and database granulates quantitative information into target genome mathematical schematics that stratify a specific cohort or demographic in order to disseminate and yield qualitative prescriptive solutions for cellular wellness and conservation.
- Why Partner With Us
- Mission & Vision
- History
- Our Capacity
-
After 50 years of identifying how to repair, regenerate and or maintain a cellular organisms we have become stewards of their optimal conservation. This entails coupling genome sequencing, big data and nutrition into an effective delivery system we call ADVANCED HYDROLIZATION that ultimately achieves CELLULAR OPTIMIZATION, a very effective anti-aging system.
INTELLECTUAL PROPERTIES
A comprehensive library of protocols, curriculums, and formulas that validate the effectiveness and success of our disruptive MULTIDIMENSIONAL HEALTH SUPPORT SYSTEM.
SUPERIOR SOLUTIONS
We design and formulate CELLULAR NUTRITION from cellular genetic specifications (i.e. what free-aminos acids are needed for a specific cellular structure) comprised of high quality nutrients and their optimal absorption.
PIONEERS IN CELLULAR NUTRITION
At the nucleus of our methodology we carefully match and formulate proteins with their amino acids to a cell's specific genetic marker and metabolic absorption requirements.
USE CASES
Our vast acumen of use cases and applications cover five main verticals: Cellular Therapies, Nutraceuticals, Vitamin & Dietary Supplements, Skincare & Haircare.
-
Our Mission
As a disruptor and responsible industry leader we strive to share knowledge via qualitative information payloads in order to build intrinsic value and ensure the evolution of the human species. Our institutional fortitude endeavors on building long lasting collaborative relationships with relevant academic bodies, associations and human initiatives. The unified goal is to heighten our industry's best practices, state of technological innovation, and elevate health standards by conducting broader in-depth research, case studies and benchmarking.
Our Vision
We envision ourselves as a key contributor and facilitator in a more sustainable future. One with zero environmental impacts, zero impoverishment, and zero disease. A future where optimal cellular conservation extends life and becomes everyone's legacy.
-
1969 - 1984 Bueno Aries, Argentina.
The research and development to identify what sustains a cell, its building blocks and how they are delivered to ensure cell revitalization and longevity. The ground work amassed a library of empirical data and hundreds of formulas that shape our present day methodology and system of cellular therapies.
1985 - 1999 Bueno Aries, Argentina.
Multifaceted collaboration focused on the study of biological and cellular therapies to share and facilitate empirical data with hundreds of doctors on the science of Biological Revitalization and Cellular Therapy. The collaboration included experts across functional medicine, endocrinology, neurology, exercise science, molecular biology, and nutritional biochemistry to help shape the system we know coin BIO-CELLULAR OPTIMIZATION™.
1986 - 1995 Bueno Aries, Argentina.
This collaboration extended its frameworks into clinical practice, medical training, and a symposium via the National Congress of Cotyledon and Placental Mesenchymal Tissue for dermal and hair revitalization. This included the design, formulation, and benchmarking of cellular therapies to aid in organ diseases and obesity
1984 - 2003 Bueno Aries, Argentina.
The Human Genome Project (HGP) was completed. HGP was an international scientific research project with the goal of determining the sequence of chemical base pairs which make up human DNA, and of identifying and mapping all of the genes of the human genome from both a physical and functional standpoint. It remains the world's largest collaborative biological project. The project was proposed and funded by the US government; planning started in 1984, got underway in 1990, and was declared complete in 2003. We were able to verify and confirm our forty (40) years of research on cellular composition and building blocks was accurate and effective as the foundation for our systems; BIO-CELLULAR OPTIMIZATION, BIO-CELLULAR NUTRITION, ADVANCED HYDROLIZATION, MULTIDIMENSIONAL HEALTH SUPPORT SYSTEM.
2003 - 2015
Our library of protocols and formulas grows to 450.
2012 - 2019
Commercialization of our cellular therapies via global licensing in the North America, South America, Europe & GCC Region.
June 2019
CULMINATE H LABS CASE STUDY - BIOFARV INTERNATIONAL established in the USA.
2017 - 2022 PROOF OF CONCEPT
Successful research, formulation, testing and benchmarking of our cellular therapies into nutraceuticals and dietary supplements.
Jan 2022 PROOF OF CONCEPT
XHUM [x factor // human // unified // management] protocol and product line presented and launched.
Feb 2023
Signed forward agreements to with expert physicians in functional medicine, anti-aging, erectile dysfunction, hormone replacement, skincare, haircare and cellular therapies to license the use of protocols and resell products.
March 2023
CULMINATE H LABS association curriculum drafted.
Dec 2023
CULMINATE H LABS library of intellectual properties transferred, established and held Delaware.
-
Our robust library of protocols, formulas, and R&D infrastructure enables a broad range of applications general or bespoke to genetic centric requirements.
95% Product Effectiveness
99% Ingredient & Product Quality
99% Hypoallergenic
95% Customer Centered Formulas
100% Science Based Nutrition
Accolades
54 Years: Stewards Of Bio-Cellular Optimization
518+: Protocols & Formulas
25+: Application Product Lines
1000+: Case Studies
5: Cohorts
